261 related articles for article (PubMed ID: 23235148)
41. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
Strong MJ; Volkening K
FEBS J; 2011 Oct; 278(19):3569-77. PubMed ID: 21810174
[TBL] [Abstract][Full Text] [Related]
42. A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred.
Williams KL; Durnall JC; Thoeng AD; Warraich ST; Nicholson GA; Blair IP
J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1286-8. PubMed ID: 19864664
[TBL] [Abstract][Full Text] [Related]
43. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.
Fallini C; Bassell GJ; Rossoll W
Hum Mol Genet; 2012 Aug; 21(16):3703-18. PubMed ID: 22641816
[TBL] [Abstract][Full Text] [Related]
44. Differential toxicity of TAR DNA-binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells.
Salvatori I; Ferri A; Scaricamazza S; Giovannelli I; Serrano A; Rossi S; D'Ambrosi N; Cozzolino M; Giulio AD; Moreno S; Valle C; Carrì MT
J Neurochem; 2018 Sep; 146(5):585-597. PubMed ID: 29779213
[TBL] [Abstract][Full Text] [Related]
45. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
[TBL] [Abstract][Full Text] [Related]
46. A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro.
Winton MJ; Van Deerlin VM; Kwong LK; Yuan W; Wood EM; Yu CE; Schellenberg GD; Rademakers R; Caselli R; Karydas A; Trojanowski JQ; Miller BL; Lee VM
FEBS Lett; 2008 Jun; 582(15):2252-6. PubMed ID: 18505686
[TBL] [Abstract][Full Text] [Related]
47. Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations.
Kühnlein P; Sperfeld AD; Vanmassenhove B; Van Deerlin V; Lee VM; Trojanowski JQ; Kretzschmar HA; Ludolph AC; Neumann M
Arch Neurol; 2008 Sep; 65(9):1185-9. PubMed ID: 18779421
[TBL] [Abstract][Full Text] [Related]
48. RNA and Protein Interactors with TDP-43 in Human Spinal-Cord Lysates in Amyotrophic Lateral Sclerosis.
Volkening K; Keller BA; Leystra-Lantz C; Strong MJ
J Proteome Res; 2018 Apr; 17(4):1712-1729. PubMed ID: 29513014
[TBL] [Abstract][Full Text] [Related]
49. Analysis of RNA metabolism in peripheral WBCs of TDP-43 KI mice identifies novel biomarkers of ALS.
Hasegawa M; Hara-Miyauchi C; Ohta H; Sakimura K; Okano H; Okano HJ
Neurosci Res; 2016 May; 106():12-22. PubMed ID: 26672899
[TBL] [Abstract][Full Text] [Related]
50. ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons.
Han JH; Yu TH; Ryu HH; Jun MH; Ban BK; Jang DJ; Lee JA
Exp Cell Res; 2013 Aug; 319(13):1998-2005. PubMed ID: 23742895
[TBL] [Abstract][Full Text] [Related]
51. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis.
Sumi H; Kato S; Mochimaru Y; Fujimura H; Etoh M; Sakoda S
J Neuropathol Exp Neurol; 2009 Jan; 68(1):37-47. PubMed ID: 19104447
[TBL] [Abstract][Full Text] [Related]
52. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.
Nonaka T; Arai T; Buratti E; Baralle FE; Akiyama H; Hasegawa M
FEBS Lett; 2009 Jan; 583(2):394-400. PubMed ID: 19111550
[TBL] [Abstract][Full Text] [Related]
53. [Molecular Pathogenesis of Amyotrophic Lateral Sclerosis].
Tsuboguchi S; Ishihara T; Sugai A; Yokoseki A; Onodera O
Brain Nerve; 2019 Nov; 71(11):1183-1189. PubMed ID: 31722304
[TBL] [Abstract][Full Text] [Related]
54. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
Prudlo J
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
[TBL] [Abstract][Full Text] [Related]
55. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
Wächter N; Storch A; Hermann A
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
[TBL] [Abstract][Full Text] [Related]
56. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
57. Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS).
Hanson KA; Kim SH; Wassarman DA; Tibbetts RS
J Biol Chem; 2010 Apr; 285(15):11068-72. PubMed ID: 20154090
[TBL] [Abstract][Full Text] [Related]
58. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
[TBL] [Abstract][Full Text] [Related]
59. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells.
Cicardi ME; Cristofani R; Rusmini P; Meroni M; Ferrari V; Vezzoli G; Tedesco B; Piccolella M; Messi E; Galbiati M; Boncoraglio A; Carra S; Crippa V; Poletti A
Sci Rep; 2018 Aug; 8(1):12390. PubMed ID: 30120266
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of heat shock factor 1 maintains TAR DNA binding protein 43 solubility via induction of inducible heat shock protein 70 in cultured cells.
Lin PY; Folorunso O; Taglialatela G; Pierce A
J Neurosci Res; 2016 Jul; 94(7):671-82. PubMed ID: 26994698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
